Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- Combination immunotherapy shrank a variety of metastatic gastrointestinal cancers
- USC Stem Cell mouse study identifies shared genes involved in hearing and vision regeneration
- Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
- The Expert Who Kept Eye Drops From Blinding You Was Fired Yesterday
- HHS layoffs hit Meals on Wheels and other services for seniors and disabled
- Paralysed man stands again after receiving ‘reprogrammed’ stem cells